Expertise in
12
conditions

Ting G. Luo

No.17 Hongqi Avenue, 
Ganzhou, CN 
Expertise in
12
conditions
No.17 Hongqi Avenue, 
Ganzhou, CN 

Overview

Ting Luo practices practicing medicine in Ganzhou, China.

Ms. Luo is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Hemophagocytic Lymphohistiocytosis, Breast Cancer, Non-Langerhans-Cell Histiocytosis, Mastectomy, and Endoscopy.

She is actively involved in clinical research, co-authoring 845 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

No.17 Hongqi Avenue, Ganzhou, 341000, China
Other Locations
No.197 Ruijin 2nd Road, Shanghai, 200025, China
172 Tongzipo Road, Changsha, 410013, China
149 Dalian Road, Zunyi, 563003, China
2nd Ruijin Road 197, Shanghai, 200025, China
118 Jiahang Road, 314-001, Jiaxing, China
345 Lingling Road, Shanghai, 200032, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

eMonarcHER: A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of Abemaciclib Plus Standard Adjuvant Endocrine Therapy in Participants With High-Risk, Node-Positive, HR+, HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy
eMonarcHER: A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of Abemaciclib Plus Standard Adjuvant Endocrine Therapy in Participants With High-Risk, Node-Positive, HR+, HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy
Enrollment Status: Terminated
Publish Date: July 15, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Study Phase: Phase 3

845 Total Publications

Ultra-narrowband organic room-temperature phosphorescence achieved by boosting low-frequency vibronic coupling.
Ultra-narrowband organic room-temperature phosphorescence achieved by boosting low-frequency vibronic coupling.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 26, 2026

Frequently Asked Questions about Ting G. Luo

Is Ting G. Luo a top-rated expert for Hemophagocytic Lymphohistiocytosis?

MediFind is an objective health platform that identifies experts based on real-world data. Ting G. Luo is classified as an Distinguished expert for Hemophagocytic Lymphohistiocytosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ting G. Luo participate in research or clinical trials?

Yes. Ting G. Luo has published 845 articles and abstracts on conditions like Hemophagocytic Lymphohistiocytosis. You can view a list of Ting G. Luo's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Luo's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 137 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile